Research Direction
Creating innovative therapeutic solutions from in-depth understanding of disease biology
Dr. Lisheng Kang <br>Chief Technology Officer（CTO）
• Be responsible for the financial management, financial strategy and capital operation of the Company
• Having paticipated the overall process from zero to IPO in the United States and Hong Kong, SAR as one of the founding management team of BGNE
• 20+ years working experience in famous multinational companies and private listed companies such as BGNE, Global IELTS, Cisco and Microsoft
• International MBA from Peking University, Bachelor of Accounting from Northeast University of Finance and Economics
Keywords:
Contacts
Add: 5-6/F, Tower B, Chongxin Building, No.13, Hangfeng Road, Fengtai District, Beijing
Tel: 010-83141848
Email: pg@primegene.net
Official WeChat
Copyright © 2021 Beijing Prime Gene Therapeutics Co., Ltd. All Rights Reserved. 京ICP备2022001152号-1 300.cn Beijing